Use of Freestyle Libre 2.0 in children with type 1 diabetes mellitus and elevated <scp>HbA<sub>1c</sub></scp>: Extension phase results after a 12‐week randomized controlled trial
Extension phase outcomes with intermittently scanned continuous glucose monitoring (isCGM 2.0) in children with T1DM and elevated HbA<sub>1c</sub> showed a sustained reduction in hypoglycaemia and increased testing frequency at 24 weeks.
Authors
- Yongwen Zhou (ORCID: https://orcid.org/0000-0002-0558-6712)
- Anita Lala
- Vicki Cunningham
- Esko Wiltshire
- Sara E. Styles
- Alisa Boucsein (ORCID: https://orcid.org/0000-0002-6266-8802)
- Benjamin John Wheeler (ORCID: https://orcid.org/0000-0003-3348-5238)
- Craig Jefferies (ORCID: https://orcid.org/0000-0002-0541-6094)
- Anna Sofia Serlachius (ORCID: https://orcid.org/0000-0002-4797-8351)
- Venus R. Michaels (ORCID: https://orcid.org/0009-0006-5675-0339)
- Hamish R. Crockett
- Bronté Chamberlain
Institutions
- University of Auckland (NZ)
- Sun Yat-sen University (CN)
- Northland District Health Board (NZ)
- Southern District Health Board (NZ)
- Urology Bay of Plenty (NZ)
- Starship Children's Health (NZ)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
- University of Waikato (NZ)
- University of Otago (NZ)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1111/dme.15494
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Starship Foundation